Showing 1 - 20 results of 9,533 for search '(( test ((greater decrease) OR (a decrease)) ) OR ( a ((large decrease) OR (marked decrease)) ))', query time: 0.59s Refine Results
  1. 1
  2. 2

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

    Published 2025
    “…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). …”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer by Ben J. Haines (22458462)

    Published 2025
    “…We have therefore generated additional derivatives which have improved mitochondrial complex 1 inhibition and reduced PDE10A inhibition. Two of these compounds were tested <i>in vivo</i> for radiosensitization of murine EO771 mammary gland tumors and found to be as effective as papaverine with an improved safety profile.…”
  15. 15

    Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer by Ben J. Haines (22458462)

    Published 2025
    “…We have therefore generated additional derivatives which have improved mitochondrial complex 1 inhibition and reduced PDE10A inhibition. Two of these compounds were tested <i>in vivo</i> for radiosensitization of murine EO771 mammary gland tumors and found to be as effective as papaverine with an improved safety profile.…”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20